Dyne Therapeutics
Presence
Dyne Therapeutics is one of the...
Dyne Therapeutics is a company listed under the stock ticker DYN (US).
Executives
View the org chart displaying its 21 main executives
Most searched biographies at Dyne Therapeutics
- John Cox, President, Chief Executive Officer and Director
- Ed Hurwitz, Director
- Lawrence Klein, Director
Popular executive movements at Dyne Therapeutics
- John Cox has joined the company as President, Chief Executive Officer and Director (posted on March 25 2024).
- Joshua Brumm, President and Chief Executive Officer, has left the company (posted on March 25 2024).
Create your alert
to follow the executive moves at Dyne Therapeutics.
Biotechnology
Dyne Therapeutics has 2,286 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).
Popular M&A news in Biotechnology
- Karius has just announced a $100 Million fundraising (posted on May 3 2024).
- Transcarent has just announced a $126 Million fundraising (posted on May 2 2024).
- WindRose Health Investors has announced the acquisition of SubjectWell (posted on May 2 2024).
Popular contacts in Biotechnology
News
Press releases by Dyne Therapeutics
- Dyne Therapeutics Reports Second Quarter 2022 Financial Results and Business Highlights | Dyne Therapeutics
- Dyne Therapeutics Announces Clearance of Clinical Trial Application for DYNE-101 for the Treatment of Myotonic Dystrophy Type 1 | Dyne Therapeutics
- Dyne Therapeutics Announces FDA Clearance of IND Application for DYNE-251 for the Treatment of Duchenne Muscular Dystrophy | Dyne Therapeutics
- Dyne Therapeutics to Present at Jefferies Global Healthcare Conference | Dyne Therapeutics
- Dyne Therapeutics Presents New In Vivo Data from DYNE-101 at ASGCT Annual Meeting Demonstrating Low Monthly Dosing Leads to Robust DMPK RNA Knockdown | Dyne Therapeutics
- Dyne Therapeutics Reports First Quarter 2022 Financial Results and Business Highlights | Dyne Therapeutics
- Dyne Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Highlights | Dyne Therapeutics
- Dyne Therapeutics Appoints Carlo Incerti, M.D., to its Board of Directors | Dyne Therapeutics
- Dyne Therapeutics to Host Virtual Research and Development Day on Wednesday, October 13, 2021 | Dyne Therapeutics
- Dyne Therapeutics to Present at Chardan’s Virtual 5th Annual Genetic Medicines Conference | Dyne Therapeutics
- View more press releases Close
Social media about Dyne Therapeutics
- Dyne Therapeutics on Wikipedia, Google News & Yahoo Finance
- Dyne Therapeutics on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including John Cox 
Call Dyne Therapeutics at +1 781...
